Physician profile
Samuel Alejandro Allen
NPI 1952503492
$4,907.91
in general payments reported to CMS, 2019-2025
9 companies · $2,020 in 2025
The $2,020 reported for 2025 was more than what 89% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,357 · 2024: $1,531 · 2025: $2,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,753 · Travel and Lodging: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,752.77 |
| Travel and Lodging | $1,155.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $1,274.22 | 2025 | Matrixcombo |
| Depuy Synthes Sales INC. | $1,265.42 | 2023-2025 | Trumatch, Matrixorthognathic, Na |
| Axogen | $779.71 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Smith+Nephew, INC. | $372.51 | 2023-2024 | Stravix Pl, Oasis, Stravix |
| Kls-Martin L.P. | $332.14 | 2024 | |
| Stryker Corporation | $295.39 | 2023-2024 | Na |
| Straumann USA LLC | $264.34 | 2023 | |
| Zimvie INC. | $183.68 | 2023-2025 | |
| Kerecis Limited | $140.50 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.